The Bacterial Vaccines (BactiVac) network brings together partners from academia, industry, and others involved in vaccine research to accelerate the development and use of vaccines against bacterial infections prevalent in ...
Read more
Author: Kate O’Brien, MD, MPH, Executive Director of the International Vaccine Access Center at Johns Hopkins University Bloomberg School of Public Health
Modeling policy decisions: Study finds new typhoid conjugate vaccine cost-effective in endemic settings
Whenever a new vaccine is approved for use, such as the newly prequalified typhoid conjugate vaccine, there are many critical policy questions at hand to determine, including who in the ...
Read moreTake On Typhoid Newsletter April 2018
See past issues in our Newsletter Archives In this issue: World Health Organization recommends typhoid conjugate vaccine Gavi welcomes country applications for typhoid conjugate vaccines Outbreak in Pakistan linked to ...
Read more
WHO recommends use of first typhoid conjugate vaccine
The World Health Organization recommends the introduction of typhoid conjugate vaccine for infants and children over six months of age in typhoid-endemic countries, helping ensure access to typhoid vaccination. Read ...
Read more
Putting policy in action to take on typhoid
Over a lifetime of work on enteric diseases (affecting the intestines), I have seen the real impact that policy changes can have on the neighbourhoods and communities where I work. ...
Read moreStatements of support for WHO’s recommendation on typhoid conjugate vaccine
Dr. Buddha Basnyat “Typhoid is responsible for nearly 12 million cases of illness and more than 128,000 deaths each year, mostly among infants and children. WHO’s recommendation on typhoid conjugate ...
Read moreWHO recommends use of first typhoid conjugate vaccine
Geneva, Switzerland – April 3, 2018 – The World Health Organization (WHO) recommends the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in ...
Read more
Launching a typhoid vaccine study in Nepal
On November 20, 2017, the Typhoid Vaccine Acceleration Consortium (TyVAC) vaccinated the first of 20,000 children against typhoid, successfully launching a study to assess the impact of typhoid conjugate vaccines ...
Read moreNepal TyVAC Trial
Identifying pathways of transmission and prevention—the SaniPath way
My work takes me to low-income urban communities all over the world, from India to Ghana, wherever possible fecal contamination could lead to the rise of diseases that sicken or ...
Read more
